The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Anderson Raymond since 2012.
This trader's CIK number is 1362489.
At the time of last reporting, Anderson Raymond was the Director of Monopar Therapeutics. (stock ticker symbol MNPR).
Also see all insider trading activities at Monopar Therapeutics.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | RPTP | 0 | $0 | 44,619 | $527,862 | 44,619 | $103,563 |
| 2014 | RPTP | 0 | $0 | 60,000 | $745,510 | 60,000 | $154,199 |
| 2013 | RPTP | 0 | $0 | 30,000 | $429,360 | 30,000 | $77,100 |
| 2012 | RPTP | 0 | $0 | 20,256 | $130,030 | 20,256 | $52,055 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | MNPR | 0 | $0 | 0 | $0 | 2,533 | $0 |
| 2023 | MNPR | 0 | $0 | 0 | $0 | 7,600 | $0 |
| 2022 | MNPR | 0 | $0 | 0 | $0 | 9,328 | $0 |
| 2021 | MNPR | 0 | $0 | 0 | $0 | 2,898 | $0 |
| 2020 | MNPR | 0 | $0 | 0 | $0 | 322 | $0 |
2. Monopar Therapeutics (MNPR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-09-02 | RPTP | Option Ex | 4,916 | 2.02 | 9,930 |
| 2015-09-02 | RPTP | Sale | 4,916 | 12.51 | 61,489 |
| 2015-08-31 | RPTP | Option Ex | 8,084 | 2.02 | 16,329 |
| 2015-08-31 | RPTP | Sale | 8,084 | 12.52 | 101,195 |
| 2015-03-24 | RPTP | Sale | 21,619 | 12.00 | 259,428 |
| 2015-03-24 | RPTP | Option Ex | 21,619 | 2.39 | 51,604 |
| 2015-01-12 | RPTP | Option Ex | 10,000 | 2.57 | 25,700 |
| 2015-01-12 | RPTP | Sale | 10,000 | 10.57 | 105,750 |
| 2014-09-10 | RPTP | Option Ex | 10,000 | 2.57 | 25,700 |
| 2014-09-10 | RPTP | Sale | 10,000 | 10.81 | 108,070 |
| 2014-07-07 | RPTP | Sale | 27,500 | 11.21 | 308,385 |
| 2014-07-07 | RPTP | Option Ex | 27,500 | 2.57 | 70,675 |
| 2014-03-07 | RPTP | Option Ex | 12,500 | 2.57 | 32,124 |
| 2014-03-07 | RPTP | Sale | 12,500 | 15.72 | 196,525 |
| 2014-01-07 | RPTP | Option Ex | 10,000 | 2.57 | 25,700 |
| 2014-01-07 | RPTP | Sale | 10,000 | 13.25 | 132,530 |
| 2013-11-07 | RPTP | Option Ex | 15,000 | 2.57 | 38,550 |
| 2013-11-07 | RPTP | Sale | 15,000 | 14.38 | 215,730 |
| 2013-09-09 | RPTP | Option Ex | 15,000 | 2.57 | 38,550 |
| 2013-09-09 | RPTP | Sale | 15,000 | 14.24 | 213,630 |
| 2012-12-28 | RPTP | Sale | 2,000 | 5.50 | 11,000 |
| 2012-12-28 | RPTP | Option Ex | 2,000 | 2.57 | 5,140 |
| 2012-10-01 | RPTP | Option Ex | 2,000 | 2.57 | 5,140 |
| 2012-10-01 | RPTP | Sale | 2,000 | 5.58 | 11,160 |
| 2012-09-12 | RPTP | Option Ex | 2,000 | 2.57 | 5,140 |
| 2012-09-12 | RPTP | Sale | 2,000 | 5.50 | 11,000 |
| 2012-06-08 | RPTP | Sale | 1,965 | 5.50 | 10,807 |
| 2012-06-08 | RPTP | Option Ex | 1,965 | 2.57 | 5,050 |
| 2012-06-07 | RPTP | Sale | 35 | 5.50 | 192 |
| 2012-06-07 | RPTP | Option Ex | 35 | 2.57 | 89 |
| 2012-04-02 | RPTP | Option Ex | 6,128 | 2.57 | 15,748 |
| 2012-04-02 | RPTP | Sale | 6,128 | 6.72 | 41,198 |
| 2012-02-28 | RPTP | Option Ex | 6,128 | 2.57 | 15,748 |
| 2012-02-28 | RPTP | Sale | 6,128 | 7.29 | 44,673 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-31 | MNPR | Option Ex | 2,533 | .00 | 0 |
| 2023-09-30 | MNPR | Option Ex | 2,533 | .00 | 0 |
| 2023-06-30 | MNPR | Option Ex | 2,534 | .00 | 0 |
| 2023-03-31 | MNPR | Option Ex | 2,533 | .00 | 0 |
| 2022-09-30 | MNPR | Option Ex | 2,859 | .00 | 0 |
| 2022-06-30 | MNPR | Option Ex | 2,859 | .00 | 0 |
| 2022-03-31 | MNPR | Option Ex | 2,859 | .00 | 0 |
| 2021-12-31 | MNPR | Option Ex | 751 | .00 | 0 |
| 2021-09-30 | MNPR | Option Ex | 751 | .00 | 0 |
| 2021-06-30 | MNPR | Option Ex | 752 | .00 | 0 |
| 2021-03-31 | MNPR | Option Ex | 751 | .00 | 0 |
| 2020-12-31 | MNPR | Option Ex | 322 | .00 | 0 |
| 2020-09-30 | MNPR | Option Ex | 322 | .00 | 0 |
| 2020-03-31 | MNPR | Option Ex | 322 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anderson Raymond (Director of Monopar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.